Purchase to create world leader in industrial biotechnology
DuPont is establishing itself as a global leader in industrial biotechnology following the acquisition of Danish enzyme and speciality food ingredients supplier, Dansico. The $6.3bn part cash, part debt agreement is expected to close in the second quarter and will be financed with approximately $3bn cash and the remainder in debt.
“This transaction is the perfect strategic fit with our growth opportunities and will help us solve global challenges,” commented DuPont chair and ceo, Ellen Kullman. “Danisco has attractive, market-driven science businesses that offer clear synergies with DuPont Nutrition & Health and Applied BioSciences.”